The purpose of the present study was to clinically and histologically investigate the influence of macrophage depletion on the development of experimental autoimmune pigment epithelial membrane protein-induced uveitis (EAPU), and experimental melanin-protein induced uveitis (EMIU) in the Lewis rat. EAPU is mainly characterized by pigment epitheliitis. Posterior mononuclear cell accumulations enclose and destroy the retinal pigment epithelium (RPE). In EMIU the inflammation is specifically localized in the uvea. EAPU was induced by immunization with RPE membrane protein, and EMIU was evoked by immunization with purified choroidal melanin. Systemic treatment with dichloromethylene diphosphonate (Cl2MDP)-containing liposomes just before the expected beginning of the clinical signs of EAPU (at day 7 and 9 after immunization) resulted in a considerable delay of the uveitis process. In the treated animals the typical plaque shaped cell accumulations (containing many macrophages) along the RPE were lacking. Two weeks after the treatment, severe rebound EAPU developed. Local treatment by subconjunctival liposome injections did not exert any effect on EAPU. In EMIU, macrophage depletion by systemic treatment did not noticeably influence the clinical and histological development of the inflammation.
1* Introduction
Three markedly different types of experimental auto immune uveitis have been described which can. be evoked in Lewis rats by immunization with uveoretinal antigens. In experimental autoimmune uveoretinitis (EAU) induced by photoreceptor proteins, inflamma tory foci develop within the photoreceptor cell layer which is the target tissue (Faure, 1980; Gery, Mochizuki and Nussenblatt, 1986) . In experimental autoimmune pigment epithelial membrane proteininduced uveitis (EAPU), the RPE is the target tissue, and inflammatory foci do not develop within the neuroretina. Mononuclear cells (mainly infiltrated macrophages) accumulate along both sides of the RPE-Bruch's membrane layer which is destroyed. Uveitogenic pigment epithelial proteins (PEP) with Mr 65, 43 and 2 8 /3 0 (PEP-65, PEP-43 and PEP-shown to be new ly recruited ED1-J-exudate macro phages. Data obtained from macrophage elimination studies indicate that the new ly recruited macrophages are crucial for the generation of clinical signs (Bauer et al., 1996, review) .
In the present study we have applied the technique of liposome-mediated macrophage depletion in order to investigate the role of macrophages in EAPU and EMIU. Liposomes containing dichloromethylene diphosphonate (CI2MDP) are know n to be phagocytized by macrophages in the spleen, the liver, and by blood monocytes (Van Rooijen et al., 1 9 9 0 ; Huitinga et al., 1990 Huitinga et al., , 1992 . Once internalized, C12MDP is released and kills the cells (Van Rooijen, 1989). EAPU and EMIU have been evoked in Lewis rats, and the animals have been injected with the liposomes immediately before the start and at the peak stage of uveitis in order to investigate a possible prevention or amelioration of uveitis.
Materials and Methods

Antigens
Two uveitogenic antigens were prepared to evoke EAPU, the Triton X -100 soluble-(TS) fraction of RPE microsomal cell membranes (RPE-TS), and its main constituent the 65 kD pigment epithelial protein PEP-65 (Broekhuyse et al., 1992b, 1 9 9 6 ). Briefly, RPE cells were isolated from the cups of fresh bovine eyes by brushing and rinsing. The cells were freed from rod outer segments and other tissue fragments by five to seven sedimentations from buffered sucrose (0*25 m; 15 h i m phosphate buffer; pH 7*3) at 140 g (10 min, 20°C). The RPE cells were extracted by phosphate buffered physiological saline pH 7*4 (PBS), and the insoluble membranous 1 0 5 g sediment was extracted by Triton X -100. The combined supernatants con taining the RPE-TS protein were stored at -25°C. Its main constituent PEP-65 was prepared from RPE-TS by preparative sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE), and electro-elution. The obtained protein was precipitated from the detergent solution by cold acetone precipitation (0°C), dried under nitrogen, dissolved in 1 % Triton X -100 in PBS, and stored at -2 5°C . PEP-65 was used as uveitogen in the initial studies of EAPU, and its activity was compared to RPE-TS.
Choroidal melanin was purified in order to evoke EMIU. Bovine eye cups were obtained as described above, and the choroid was removed with forceps. The tissues were rubbed in a mortar w ith a rough surface with minimal amounts of water. The suspended material was filtered through gauze, and the ex traction of the tissue was repeated five times. The combined filtered suspensions were centrifuged (1 0 4 g , 10 min, 4°C), and the crude sedimented melanosomes were washed with PBS. Afterwards they were sus pended in 2 % SDS in distilled water (1 ml for the melanin of each choroid), and heated at 75°C for 10 min. After centrifugation, the purified melanin was washed twice with distilled water at room tem perature, and stored in water at -25°C .
The determinations of soluble, membrane-, and melanin-protein, SDS-PAGE, the check for purity by SDS-PAGE and immunoblotting have been described previously (Broekhuyse et al., 1991 (Broekhuyse et al., , 1992a (Broekhuyse et al., , b, 1993 .
Animal Experiments
Groups of female Lewis rats [LEW/01a/Hsd(albino); 1 5 0 -1 8 0 g] composed as represented in Table I, Shortly before, or after the start of EAPU and EMIU, the animals were intravenously injected with 1-8 ml Cl2MDP-liposomes, PBS-containing liposomes, or PBS, as indicated in the Results section (Table I ). In a separate experiment, 50 ¡A ClaMDP-liposomes were injected subconjunctivally at the right eyes of five rats at day 7 and 9 after immunization. Liposomes were prepared as described (Huitinga et al., 1995) . C12MDP was a gift of Boehringer, Mannheim, Germany, Starting from day 9 after immunization, the eyes were examined daily for 2 weeks and subsequently twice a week. Clinical signs of uveitis were monitored by direct slit-lamp biomicroscopy after dilation of the pupils by tropicamide (0*17%). The observations were graded on a scale of 0 -4 as described for EAPU (Broekhuyse et al., 1992b) , and for EMIU (Broekhuyse et al, 1991) . The experiments were terminated 2 to 4 weeks after immunization as indicated in Table I , and the histopathology of eyes, liver and spleen was examined.
Histopathology
Eyes were fixed in Bouin solution, and processed according to standard histological techniques. All eyes were sectioned parallel to the optic axis. Macrophage depletion phenom ena were checked in frozen sections of spleen, liver and in bloodsmears of rats 2 weeks after immunization. Bloodsmears were stained with May Grunwald-Giemsa, and frozen sections were stained with monoclonal antibody EDI as described (Broek huyse et a l, 1996). * C12M D P , PBS: mannosylated liposomes containing C12M D P or PBS were injected intravenously shortly before or after the start of E A P U or E M IU , i.e. at days 7 and 9 (and 12) (prevention) or 12 and 14 (therapy), respectively. [PBS solution], P B S injected without liposomes. t M axim um score attained within the entire experimental period. Mild, score 1 and 2 ; severe, score 3 and 4.
% No m axim um inflammation reached in ail rats; incidences at day 12 are represented, the time of the first injection of liposomes close to the inflammatory peak activity of EAPU . § M ean score ( ± s.e .m .). Early phase, day 12-15 after immunization, shortly after the start of E A P U or EMIU (peak of inflammation) w h e n the most characteristic effects of treatment are noticed; late phase, day 26-30. P values represent analysis of scores of Cl2MDP-liposomes treated rats vs, control rats. **P < 0-01, ***P < 0*05. **** Analysis of PBS-liposomes-treated rats vs. PBS-injected rats: P < 0-01. U Melanin injected in two different melanin-protein doses to evoke EMIU: 25 (ig (2 /¿g pertussis toxin), and 1 0 /¿g (1 /¿g pertussis toxin).
Statistical Analysis
For testing the significance of difference in uveitis scores, Fisher's exact test was applied.
. Results
Clinical Effects of Macrophage Depletion
EAPU treatment, Cl2MDP-lipo somes at day 7 and 9; controls Table I represents the results of two types of experiments in Lewis rats which were immunized to develop EAPU. In the first type of experiment, C12MDPliposomes were injected intravenously just before and at the day on which clinical signs of ocular inflammation were expected to start. The results of slit-lamp examinations show that PEP-65 in PBS controls evoked severe EAPU (score 3*4 at day 13). If the rats were treated with C12MDP-liposomes at day 7 and 9 after immunization, only a very mild vitritis was noticed (score 1*6 at day 13). The inhibition of uveitis was not permanent because EAPU still developed two weeks later (score 3*3 at day 26). PBS~liposomes (control treatment) also had a weak inhibiting effect on the disease ; the highest score attained in controls was 2*4 (day 13). The scores of both control groups finally decreased to 1*3 (day 26). Two similar experiments (not recorded in Table I ) confirmed this effect of PBSliposomes. It occurred from day 12 to 20, and disappeared afterwards. Hence, all three groups de veloped uveitis but according to different patterns. Because the experiments described below showed that RPE-TS and PEP-65 were equally w ell suitable to evoke EAPU while RPE-TS was easier to prepare, this antigen was further used as the inciting uveitogen. Table I shows that control rats injected with RPE-TS developed severe EAPU (peak inflammation at day 12 ; score 2*5) at day 12 whereas Cl2MDP-liposomes treatment totally inhibited the development of clinical EAPU at that time. Like in PEP-65-induced EAPU treated with Cl2MDP-liposomes, the disease still de veloped a few weeks later, in controls on the other hand, the signs of clinical EAPU gradually decreased. ClgMDP-liposomes deposition subconjunctivally at one eye, did not result in macrophage depletion and suppression of EAPU. The uveitis scores were equally high for treated (OD) and untreated eyes (OS) at the time uveitis was at its peak of inflammation (scores 3*0 to 3-3 at day 13). EAPU treatment, controls In the second type of experiments, therapeutic treatment of EAPU at the time of its peak stage was investigated. Cl2MDP-liposomes were intra venously injected at day 12 and 1 4 w hen moderate to severe EAPU was clinically manifest (Table I) . / V ' . :
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, Histopathology of EAPU in Lewis rats treated with CI2MDP»liposomes (suppression) or PBS-liposomes (controls), (A) Severe EAPU in controls at day 13 after immunization (PBS-liposomes at day 7 and 9). Subretinal exudate, subretinal and choroidal cell accumulations extending into the dystrophic ciliary body. The RPE has been eliminated, x 170. (B) Absence of EAPU at day 13 after immunization as a result of suppression of uveitis by macrophage elimination by ClaMDP-liposome injections at day 7 and 9. Scarce mononuclear cells infiltrated into the choroid and vitreous, x 340. (C) Severe EAPU at day 26 after immunization following initial suppression by Cl2MDP-liposome injections at day 7 and 9. Dense chorio-subretinal mononuclear cell accumulations along the destroyed RPE. No inflammatory foci within the neural retina, x 340. (D) Late stage (day 26 after immunization) of very severe EAPU after treatment of the disease by Cl2MDP-liposome injections at day 12 and 14 after immunization. Subretinal fibrosis and decay of phagocytes, irregular nuclear layers, dystrophic and absent rod outer
segments. x l7 0 . experimental period of 2 6 days no recurrence of clinical EAPU was observed in treated rats while the score in controls changed from 2-9 to 1-8 mainly because vitritis gradually decreased.
EM1U treatment, Cl2MDP-liposomes at day 7 and 9 (and 12); controls EMIU was induced by two different doses melanin-protein, 10 and 25 /¿g, accompanied by 1 and 2 /¿g pertussis toxin, and the rats were injected with liposomes at day 7 and 9 or at day 7 and 9 and 12, respectively. Table I shows 1(A) ]. No polymorphonuclear cells or plasma cells were found. The majority of the mononuclear cells were macrophages, but these cells were not found within the photoreceptor cell layer. No inflammatory foci were found to develop within the neuroretina.
Four weeks after immunization of the controls, the cell accumulations had extended still further along both sides of the RPE suggesting that the process of cell accumulation progressed continuously. Many ac cumulations were situated at the chorioretinal per iphery, and in very severe inflammatory reactions the ciliary body became involved. The layer of retinal rods showed thinned areas without the presence of inflam matory cells, and was focally absent. The iris and ciliary body contained only slight mononuclear cell infiltrations even at this advanced stage, Sclera and cornea were not involved. We found no differences between the patterns of EAPU development evoked by PEP-6 5 and by RPE-TS. The higher slit-lamp scores in rats with PEP-65 induced EAPU and injected w ith PBS histopathologically corresponded to more severe cho roiditis while the cell accumulations were more extensive. EAPU treatment, Liver and spleen sections exhibited efficient elimination of EDI H-macrophages by the Cl2MDP-liposomes in agreement with a previous report (Van Rooijen et al., 1990), while bloodsmears showed the presence of enlarged and vacuolated monocytes indicating that the cells were affected by the Cl2MDP-liposomes . In contrast to the observations in control rats, clinical uveitis scores and histopathological observations often did not correspond in the treated groups. In the early stage [day 13], chorio retinal cell infiltrations were absent in the RPE-TSimmunized rats treated with Cl2MDP-liposomes w hich were clinically without signs of uveitis. Yet, slight vitreous cell infiltrations were found in eye sections [Fig. 1(B) ]. Some small chorioretinal inflammatory foci were found in the similarly treated PEP-6 5-immunized rats indicating a slightly higher pathogenicity of this antigen at the applied dose. Two weeks later, severe rebound EAPU developed in both groups. Extensive cell accumulations were then noted along both sides of the RPE [Fig. 1(C) ]. At this late stage, the choroid and retinal photoreceptor layer became more or less dystrophic, and the rod outer segments were often disappearing, depending on the severity of EAPU that developed. The phenom ena further closely resembled EAPU in controls at its peak stage, Subconjunctivally injected Cl2MDP~liposomes did not inhibit EAPU, and the eyes of these rats and the corresponding controls exhibited the typical histo logical features of the peak stage of severe EAPU at the moment of termination of the experiment, day 13. Liver and spleen sections of both groups did not exhibit EDI + macrophage depletion. The histopathology of the early [day 12 and 15] and late [day 26] stages exhibited a similar appearance as noted in undisturbed EAPU development at the same timepoints, EAPU treatment, In these experiments, the C12MDP-and PBS-liposomes were injected at the peak stage of EAPU development of the group. The histopathological features of this stage in controls have been described above. Clinically, the treated group exhibited a sudden drop in uveitis activity by the disappearance of vitreous and anterior chamber cells during the two days following the injections (as reflected in a drop in the uveitis score, Table I ). However, both the sections of eyes enucleated at day 15 and at day 26 exhibited the characteristic histopathological features of the peak stage of EAPU. Hence, already deposited cell accum ulations along the RPE [Fig. 1(D) ] seemed neither to regress nor to expand during the period of disappearance and absence of the clinical uveitic changes (days 1 2 -2 6 ). The number of inflammatory foci also remained constant during this period.
EM1U treatment: Cl2MDP-liposomes at day 7 and 9, and 7 and 9 and 12; controls Histopathological examination confirmed the clinical observation that Cl2MDP-liposome treatment did not inhibit or ameli orate EMIU. At the onset of EMIU, the entire uvea was densely infiltrated by m ononuclear cells [predomin antly lymphoid cells; Fig. 2(A ) ]. The anterior uvea was swollen and atrophic, These aspects were not different from the ocular histopathology of the PBS-liposome and PBS-solution control groups, The neuroretina was neither affected in the controls nor in the treated rats [ Fig. 2(B) ]. Sections of liver and spleen showed an effective depletion of macrophages. General controls: no antigen, no treatment In the eyes of the general controls w e did n ot find any sign of inflammation.
Discussion
Effect of Cl2MDP-liposomes
Among the m any possibilities to stop uveoretinitis especially corticosteroids, and more recently cyclo sporin have been used in patients. The latter substance also suppresses EAU, EMIU and EAPU as these are T~ cell dependent diseases (Gery et al.t 1 9 8 6 ; Broekhuyse  e t ' al., 1992a; 1992b ; 1 9 9 3 ) . As described above (Introduction), these forms of autoim mune uveitis exhibit different characteristics, and are evoked by antigens originating from different retinal or uveal cell types. The present study shows that hematogenous macrophages are of crucial importance for the gen eration of EAPU because macrophage depletion by ClgMDP-containing liposomes results in a two weeks lasting suppression of EAPU. This treatment is es pecially effective if applied just before the appearance of the first clinical signs of inflammation, i.e. at day 7 and 9. Treatment at day 8 and 10 appeared to be equally effective but injections at earlier or later points of time injection were less inhibitory (results not shown), in agreement with the findings for EAE suppression by the same protocols (Huitinga et aLt 1990) . Previous studies have demonstrated that Cl2MDP-containing liposomes have no effect on the functioning of other cells of the immune system (Claassen, Van Rooijen and Claassen, 1990 ). Liposomes-encapsulated C12MDP is internalized by the macrophages in liver and spleen, and by the blood monocytes (Van Rooijen, 1 9 8 9 ; Huitinga et al., 1990; 1992) . As a result, the relative concentration of monocytes decreases whereas increased proportions of enlarged and desintegrating blood monocytes, and polymorphonuclear cells are observed after liposome injections. Repopulation of the depleted tissues and blood has been observed within two weeks. This corresponds to the period of about two weeks after which EAPU started to develop after the initial suppression by Cl2MDP-liposome injections at day 7 and 9. Macrophage depletion thus seems to be the sole or main cause of the suppression of EAPU. PBSliposomes slightly ameliorate EAPU, presumably be cause they are similarly phagocytized by blood monocytes as Cl2MDP~liposomes, and occupy phago cytic capacity.
Ocular penetration of liposomes before the onset of uveitis in a w ay that noticeably influences the RPE or other crucial tissue cells in EAPU seems unlikely. Investigations of the central nervous system using the same conditions and type of liposomes showed that the liposomes could not cross the blood-brain barrier until it was damaged by the inflammatory response (Huit inga, 1992). We did not observe histological alteration of retina or uvea in the period between the first intravenous liposome injection and the onset of EMIU w hen the liposome concentrations were highest while the blood-ocular barrier was still intact (Broekhuyse et al., unpublished result). Subconjunctivally deposited Cl2MDP-liposomes did not exert any influence on the development of EAPU showing that these liposomes do not easily migrate through the tissues. Furthermore, no focal modification of the disease process was noted during the development of the uveitis process when (remaining) liposomes could have entered the eye via the damaged blood-ocular barrier. At that site, the functionally important RPE cells were immediately destroyed by infiltrating effector cells. In agreement with thkse considerations, the features of EMIU as well
